X2HM0F9
Insertion Axillary Artery, Left to New Technology Group 9 with Conduit to Short-term External Heart Assist System, Open Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | X New Technology |
| Body System | 2 Cardiovascular System |
| Operation | H Insertion |
| Body Part | M Axillary Artery, Left |
| Approach | 0 Open |
| Device | F Conduit to Short-term External Heart Assist System |
| Qualifier | 9 New Technology Group 9 |
Operation Definition
Putting in a nonbiological appliance that monitors, assists, performs, or prevents a physiological function but does not physically take the place of a body part
Procedure Overview
This family covers implanting a nonbiological device into the heart or a blood vessel that monitors or supports a physiological function without replacing any tissue itself. A common example is a leadless cardiac pacemaker, a self-contained capsule placed directly inside a heart chamber through a catheter rather than through a surgically implanted pulse generator with wire leads. The device senses the heart's electrical activity and delivers pacing impulses as needed, addressing slow or irregular heart rhythms.
Because the New Technology section exists to track devices recently approved for distinct reimbursement and outcomes monitoring, these procedures are typically newer catheter-based alternatives to long-established open or lead-based techniques. Patients considering them are often candidates who face higher risk from traditional lead placement, such as those with prior infections or difficult venous access.
Anatomy & Axis Detail
Axillary Artery, Left
The left axillary artery mirrors its right-sided counterpart in supplying the upper limb and offers a similar alternative to femoral access for inserting devices, particularly favorable in patients whose lower-extremity or central vessels are diseased, tortuous, or otherwise unusable. Because it sits beneath the pectoral muscles and near the brachial plexus, insertion here may involve a surgical cutdown to expose the vessel safely, though percutaneous techniques are also used. Selection of the left side over the right can depend on operator handedness, coexisting arm pathology, or the need to preserve one side for future vascular access. Devices placed here that support ambulation during treatment are one reason this vessel has grown in use, and documentation should reflect the left-sided approach distinctly from right axillary procedures.
Approach: Open
Open approach in New Technology denotes access to the target site through a surgical incision that exposes the body part directly to view and instrumentation. It stands apart from percutaneous and endoscopic approaches, which achieve access through small punctures or existing openings rather than a deliberate surgical opening of tissue.
Device / Substance / Technology: Conduit to Short-term External Heart Assist System
This device value describes a conduit created to connect the patient's circulation to a short-term external heart assist system, such as a temporary ventricular assist device used to support cardiac output during acute decompensation. It is distinguished from conduits leading to permanent or implantable assist devices by the external, temporary nature of the connected system. The value captures the vascular access pathway rather than the pump itself.
Qualifier: New Technology Group 9
Group 9 is the seventh-position qualifier used in the New Technology section to mark a device, substance, or technique as belonging to the 2022 annual cohort of new technology add-on codes. It has no clinical meaning of its own beyond that vintage tag, so coders rely on the specific table and body system to know what procedure it applies to. It is distinguished from Group 8 and Group 10 purely by the fiscal year the technology was approved for separate identification.
Coding & Documentation
Coders need the operative note to confirm the specific brand or device named in the New Technology table entry, since these codes are device-specific rather than generic. Documentation should state the approach (typically percutaneous), the target chamber, and confirmation that the device itself performs the monitoring or assistive function rather than serving as a structural replacement. A frequent error is defaulting to the standard Cardiovascular section code for pacemaker or device insertion instead of checking whether the specific model qualifies for a New Technology designation, which can materially change reimbursement. Another common miss is failing to update code selection when a device's New Technology group value changes between annual code set updates.
Commonly Confused With
This is easily confused with standard Insertion procedures coded in the regular Cardiovascular System section, where the distinguishing factor is solely whether the device brand appears in the New Technology reference table for that year. It is also distinct from Replacement, which applies when the device or material takes over the physical role of a body part rather than simply monitoring or assisting it.